UK Pharma Takes Hope From Draft Brexit Deal But Uncertainty Reigns

The Brexit deal agreed by UK ministers brings little certainty for the life sciences sector.  Moreover, the related and unprecedented political instability means that its final approval is far from guaranteed. 

People's vote
The Brexit deal brings little certainty for life sciences and faces an uncertain future. • Source: Shutterstock

The announcement that a draft Brexit deal has been negotiated between the UK and the EU and agreed by the UK Cabinet was greeted with some relief by the life sciences industry as offering a degree of certainty for the sector, not least because of the proposed transition period in the agreement that would avoid a “cliff-edge” Brexit in March next year.

It is far from clear whether the draft agreement will in fact become the final deal, but Mike Thompson, CEO...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet